Insulin infusion pump therapy has dramatically improved over the past 20 years and can now address some of the specific challenges related to toddlers with diabetes. We discuss both the non-randomized and randomized controlled trials comparing continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in this age group. There are advantages and disadvantages related to both CSII and MDI treatments, and ultimately the decision to use CSII should be individualized for each patient and family with the guidance of their diabetes team.
Get full access to this article
View all access options for this article.
References
1.
Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999. Diabet Med, 2006; 23:857–866.
2.
DabeleaD. The accelerating epidemic of childhood diabetes. Lancet, 2009; 373:1999–2000.
3.
KarvonenM, Viik-KajanderM, MoltchanovaE, LibmanI, LaPorteR, TuomilehtoJ. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care, 2000; 23:1516–1526.
4.
PattersonCC, DahlquistGG, GyurusE, GreenA, SolteszG. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet, 2009; 373:2027–2033.
5.
WagnerVM, GrabertM, HollRW. Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial—a large-scale multicentre study. Eur J Pediatr, 2005; 164:73–79.
6.
BerghaeuserMA, KapellenT, HeidtmannB, HaberlandH, KlinkertC, HollRW. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes, 2008; 9:590–595.
7.
DiMeglioLA, PottorffTM, BoydSR, FranceL, FinebergN, EugsterEA. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr, 2004; 145:380–384.
8.
JakischBI, WagnerVM, HeidtmannB, LeplerR, HolterhusPM, KapellenTM, VogelC, RosenbauerJ, HollRW. German/Austrian DPV Initiative and Working Group for Paediatric Pump Therapy: Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 years. Diabet Med, 2008; 25:80–85.
9.
Mack-FoggJE, OrlowskiCC, JospeN. Continuous subcutaneous insulin infusion in toddlers and children with type 1 diabetes mellitus is safe and effective. Pediatr Diabetes, 2005; 6:17–21.
10.
NabhanZM, KreherNC, GreeneDM, EugsterEA, KronenbergerW, DiMeglioLA. A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes. Pediatr Diabetes, 2009; 10:202–208.
11.
RabboneI, BobbioA, DiGianniV, SacchettiC, CeruttiF. Intensive insulin therapy in preschool-aged diabetic children: from multiple daily injections to continuous subcutaneous insulin infusion through indwelling catheters. J Endocrinol Invest, 2008; 31:193–195.
12.
RabboneI, ScaramuzzaA, BobbioA, BonfantiR, IafuscoD, LombardoF, ToniS, TuminiS, CeruttiF. Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion. Diabetes Technol Ther, 2009; 11:707–709.
13.
WilliSM, PlantonJ, EgedeL, SchwarzS. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr, 2003; 143:796–801.
14.
WilsonDM, BuckinghamBA, KunselmanEL, SullivanMM, PaguntalanHU, GitelmanSE. A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care, 2005; 28:15–19.
15.
WeinzimerSA, AhernJH, DoyleEA, VincentMR, DziuraJ, SteffenAT, TamborlaneWV. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601–1605. Erratum in: Pediatrics, 2005; 115:518.
16.
JehaGS, KaravitiLP, AndersonB, SmithEO, DonaldsonS, McGirkTS, HaymondMW. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther, 2005; 7:876–884.
17.
LittonJ, RiceA, FriedmanN, OdenJ, LeeMM, FreemarkM. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr, 2002; 141:490–495.
18.
FoxLA, BucklohLM, SmithSD, WysockiT, MaurasN. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care, 2005; 28:1277–1281.
19.
Opipari-ArriganL, FredericksEM, BurkhartN, DaleL, HodgeM, FosterC. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabetes, 2007; 8:377–383.
20.
KapellenTM, HeidtmannB, BachmannJ, ZieglerR, GrabertM, HollRW. Indications for insulin pump therapy in different age groups: an analysis of 1,567 children and adolescents. Diabet Med, 2007; 24:836–842.
21.
ShehadehN, BattelinoT, GalatzerA, NavehT, HadashA, de VriesL, PhillipM. Insulin pump therapy for 1–6 year old children with type 1 diabetes. Isr Med Assoc J, 2004; 6:284–286.
22.
Sullivan-BolyaiS, DeatrickJ, GruppusoP, TamborlaneW, GreyM. Mothers' experiences raising young children with type 1 diabetes. J Spec Pediatr Nurs, 2002; 7:93–103.
23.
Sullivan-BolyaiS, KnaflK, TamborlaneW, GreyM. Parents' reflections on managing their children's diabetes with insulin pumps. J Nurs Scholarsh, 2004; 36:316–323.
24.
TamborlaneWV, SherwinRS, GenelM, FeligP. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med, 1979; 300:573–578.
ZinmanB. Insulin pump therapy and rapid acting insulin: what have we learned?Int J Clin Pract Suppl, 2001; 123:47–50.
27.
HompeschM, McManusL, PohlR, SimmsP, PfütznerA, BülowE, FlackeF, HeinemannL, SteinerSS. Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin. J Diabetes Sci Technol, 2008; 2:568–571.
28.
SteinerS, HompeschM, PohlR, SimmsP, FlackeF, MohrT, PfütznerA, HeinemannL. A novel insulin formulation with a more rapid onset of action. Diabetologia, 2008; 51:1602–1606.
29.
EugsterEA, FrancisG. Position statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics, 2006; 118:e1244–e1249.
